Vivasure Medical to exhibit at TCT 2019
Galway, Ireland – September 16, 2019 – Vivasure Medical will be exhibiting at TCT 2019, which will take place at the Moscone Centre in San Francisco from the 25th-29th September. We will host a demonstration area on our booth (#2259) offering attendees a hands-on experience with the PerQseal® large arteriotomy closure device and an opportunity to speak with our technology experts.
Vivasure’s PerQseal Technology will be presented during the following TCT sessions:
Thursday 26 September 2019
Large-Bore Vascular Access and Closure – Moderated Posters 3
Location: Moderated Poster Area
Results of the Frontier IV Study with the PerQseal Absorbable Patch Based Large Hole Vascular Closure Device
Presenter: Dr. Arne G. Schwindt
Friday 27 September 2019
Session II: Technology Forum Part 2 – Access and Closure Alternatives, Innovation Gone Wild
Location: Room 155/157
Large Hole Transfemoral Closure I;
The PerQseal Device
Presenter: Dr. Jeffrey Popma
PerQseal is a new large arteriotomy closure device which utilises an intravascular patch, to seal the arteriotomy from the inside, without the use of collagen, sutures, or metal. It is comprised of a synthetic, fully-absorbable, polymer implant, and an easy-to-use, ergonomically designed delivery system. After deployment, the implant is rapidly endothelialised and fully absorbed.
PerQseal is CE Mark approved and is not available for sale in the United States.
About Vivasure Medical
Based at one of Europe’s largest medtech hubs in Galway Ireland, Vivasure is focused on the development of absorbable implant technologies with vascular applications. Vivasure operates a fully integrated R&D and ISO 13485 certified manufacturing facility and is backed by leading international medtech investors.